According to a document sent by the Health Ministry to a Senate enquiry on Thursday, Brazil is in talks to purchase up to 150 million doses of the Pfizer (PFE.N) COVID-19 vaccine for next year.
The document was shared with the enquiry, which is looking into Brazil’s response to the pandemic, after senators asked for information on the country’s vaccination campaign for next year.
The Health Ministry stated that it was in talks with Pfizer about purchasing 100 million doses, with the possibility of acquiring another 50 million doses.
On top of the Pfizer vaccine, Brazil will rely on the Astrazeneca (AZN.L) shot which it produces in the country – currently with imported active ingredients.
Brazil has the world’s second highest COVID-19 death toll, behind only the United States. President Jair Bolsonaro has been criticized by health experts for his mismanagement of the outbreak, railing against lockdowns and regularly refusing to wear a mask in public.
Despite a slow start, Brazil has ramped up a successful vaccination campaign. Over 70% of Brazilians have now received a first dose, compared to 65% in the United States.